(MR)

Mindray Medical International Limited

Close Price:
30.69

Change:
0.03 Stock Price Increase0.03

% Change:
0.000978473581213307240704501 Stock Price Increase0.10 %

Date:
5/18/2012

52 Week:
21.25 - 34.07

Prev Close:
30.66

Open:
30.80

Volume:
329,894

90D Avg. Volume:
482,231

5/18/2012 Range:
30.56 - 31.38

Market Cap:
3,560,653,800

Trailing PE Ratio:
21.92

Shares Out:
116,020,000

EPS:
1.40

Yield:
0.00

Dividend:
0.00

Dividend Date:
3/29/2012

Quarter End:
6/30/2012

Mindray Medical International Limited

Sector: Healthcare

Industry: Medical Instruments & Supplies

Website: www.mindray.com

Business Summary: Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers patient monitoring devices that track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. This segment?s products include single and multiple-parameter monitors, mobile and portable multifunction monitors, central stations that collect and display multiple patient data on a single screen, electro-cardiogram monitoring devices, veterinary monitoring devices, anesthesia machines, defibrillators, surgical beds, surgical lights ceiling pendants, syringes, infusion pumps, and ventilators. Its products are suitable for adult, pediatric, and neonatal patients and are used principally in hospital intensive care units, operating rooms, and emergency rooms. The In-Vitro Diagnostic Products segment offers data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment, as well as semi-automated and fully-automated in-vitro diagnostic products for laboratories, clinics, and hospitals. This segment?s product portfolio comprises hematology, biochemistry, urine sediment, and microbiology analyzers. The Medical Imaging Systems segment provides ultrasound systems for use in medical fields, such as urology, gynecology, obstetrics, and cardiology; digital radiography systems; magnetic resonance imaging systems; and picture archiving and communication systems. The company sells its products directly to hospitals, clinics, and government health bureaus, as well as to original design manufacturers and original equipment manufacturers. Mindray Medical International Limited was founded in 1991 and is headquartered in Shenzhen, the People?s Republic of China.


Mindray Building
Keji 12th Road South
Shenzhen, 518057 China China
P: 86 755 8188 8666
F: 86 755 2658 2500

MR Earnings Calendar

Q1:
Dec
31
 -
Mar
30
Q2:
Mar
31
 -
Jun
30
Q3:
Jun
30
 -
Sep
29
Q4:
Sep
30
 -
Dec
30
Period Ending
 
Assets
Current Assets
Cash & Cash Equivalents
Short Term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
Long Term Assets
Property Plant & Equipment
Goodwill
Intangible Assets
Accumulated Amortization
Other Assets
Deferred Long Asset Charges
Total Assets
Liabilities
Current Liabilities
Accounts Payable
Short/Current Long Term Debt
Other Current Liabilities
Total Current Liabilities
Long Term Debt
Other Liabilities
Deferred Long Term Liability Charges
Minority Interest
Negative Goodwill
Total Liabilities
Stockholders' Equity
Misc Stock Options Warrants
Redeemable Preferred Stock
Preferred Stock
Common Stock
Retained Earnings
Treasury Stock
Capital Surplus
Other Stockholder Equity
Total Stockholder Equity
Net Tangible Assets
12/31/2009
 
 
 
$306,485
$0
$133,196
$64,518
$0
$511,665
$0
$153,726
$115,053
$89,841
$0
$95,980
$0
$966,265
 
 
$145,863
$108,775
$0
$254,638
$66,000
$1,342
$3,734
$2
$0
$325,714
 
$0
$0
$0
$14
$0
$0
$298,408
$40,651
$640,549
$435,655
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
YoY
 
 
 
41.8%
(100.0%)
18.3%
12.3%
0.0%
19.7%
(100.0%)
21.6%
0.7%
28.9%
0.0%
5,467.3%
0.0%
23.0%
 
 
18.8%
(30.7%)
0.0%
(9.0%)
0.0%
(81.2%)
407.3%
0.0%
0.0%
13.2%
 
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
8.5%
3.7%
28.6%
38.7%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
12/31/2008
 
 
 
$216,081
$36,780
$112,584
$57,466
$0
$427,414
$46,275
$126,399
$114,234
$69,725
$0
$1,724
$0
$785,771
 
 
$122,814
$157,007
$0
$279,821
$0
$7,120
$736
$2
$0
$287,679
 
$0
$0
$0
$14
$0
$0
$274,993
$39,199
$498,092
$314,133
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
YoY
 
 
 
14.3%
(34.2%)
223.4%
131.6%
0.0%
39.5%
(11.6%)
163.0%
582.1%
242.7%
0.0%
(36.0%)
0.0%
75.9%
 
 
90.0%
0.0%
(100.0%)
303.8%
0.0%
0.0%
(78.3%)
0.0%
0.0%
295.8%
 
0.0%
0.0%
0.0%
(6.7%)
0.0%
0.0%
(2.7%)
498.7%
33.2%
(6.8%)
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
Period Ending
Net Income
Operating Activities
Depreciation
Adjustments To Net Income
Changes In Accounts Receivables
Changes In Liabilities
Changes In Inventories
Changes In Other Operating Activities
Total from Operating Activities
Investing Activities
Capital Expenditures
Investments
Other Investing Activities
Total from Investing Activities
Financing Activities
Dividends Paid
Sale Purchase of Stock
Net Borrowings
Other Financing Activites
Total from Financing Activities
Effect of Exchange Rate Changes
Change in Cash and Cash Equivalents
12/31/2009
$139,188
 
$27,899
$19,129
($23,496)
$17,895
($5,523)
($2,842)
$172,250
 
($56,485)
($146,501)
$177,987
($68,136)
 
($21,598)
$13,177
$12,072
$0
$3,651
$93
$107,765
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
YoY
28.1%
 
24.6%
(14.7%)
68.7%
(18.0%)
3.1%
(77.6%)
85.4%
 
(27.1%)
(554.8%)
155.1%
79.7%
 
(12.1%)
113.7%
(92.2%)
0.0%
(97.4%)
(98.7%)
216.3%
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
12/31/2008
$108,687
 
$22,399
$22,436
($75,121)
$21,817
($5,702)
($1,600)
$92,916
 
($44,440)
$32,215
($322,795)
($335,020)
 
($19,267)
$6,166
$155,304
$0
$142,203
$7,226
($92,675)
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
YoY
34.0%
 
135.6%
167.2%
(347.4%)
(9.2%)
30.3%
(61.3%)
(4.3%)
 
(40.1%)
135.0%
(182,470.1%)
(171.4%)
 
(16.3%)
(34.9%)
3,216.7%
0.0%
1,276.9%
205.4%
(104.5%)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research Development
Selling General & Administrative
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes
Interest Expense
Income Before Tax
Income Tax Expense
Minority Interest
Net Income From Continuing Ops
 
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares
12/31/2009
$634,183
$280,319
$353,864
 
$58,383
$154,869
$0
$0
$0
$140,612
 
$32,099
$172,711
$4,759
$167,952
$28,764
$0
$139,188
 
 
$0
$0
$0
$0
$139,188
$0
$139,188
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
YoY
15.8%
11.9%
19.2%
 
12.4%
28.1%
(100.0%)
0.0%
0.0%
19.7%
 
141.7%
32.0%
(7.8%)
33.7%
69.7%
0.0%
28.1%
 
 
0.0%
0.0%
0.0%
0.0%
28.1%
0.0%
28.1%
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
12/31/2008
$547,527
$250,573
$296,954
 
$51,945
$120,890
$6,600
$0
$0
$117,519
 
$13,279
$130,798
$5,163
$125,635
$16,948
$0
$108,687
 
 
$0
$0
$0
$0
$108,687
$0
$108,687
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
YoY
79.0%
81.6%
76.9%
 
76.1%
119.0%
0.0%
0.0%
0.0%
41.3%
 
5.7%
36.7%
42,925.0%
31.3%
16.1%
0.0%
34.0%
 
 
0.0%
0.0%
0.0%
0.0%
34.0%
0.0%
34.0%